Login to Your Account

Other News To Note

Monday, January 9, 2012

• Microbix Biosystems Inc., of Toronto, and Zydus Cadila, of Ahmedabad, India, signed a letter of intent to market thrombolytic drug Urokinase in North American markets. Microbix acquired rights to the drug in 2008. Financial terms were not disclosed.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription